Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Schöll, Michaela | Almkvist, Oveb; c | Bogdanovic, Nenadd | Wall, Anderse | Långström, Bengtf | Viitanen, Mattib | Nordberg, Agnetaa; b; *
Affiliations: [a] Department of Neurobiology, Care Sciences and Society, Division of Alzheimer Neurobiology, Karolinska Institutet, Stockholm, Sweden | [b] Department of Neurobiology, Care Sciences and Society, Division of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden | [c] Department of Psychology, Stockholm University, Stockholm, Sweden | [d] Department of Neurobiology, Karolinska Institutet – Alzheimer's Disease Research Center, Care Sciences and Society, Stockholm, Sweden | [e] Uppsala Imanet AB, GE Healthcare, Uppsala, Sweden | [f] Department of Biochemistry and Organic Chemistry, Uppsala University, Uppsala, Sweden
Correspondence: [*] Correspondence to: Professor Agneta Nordberg, MD, PhD, Department of Neurobiology, Care Sciences and Society, Division of Alzheimer Neurobiology, Karolinska Institutet, 141 86 Stockholm, Sweden. Tel.: +46 8 585 854 67; Fax: +46 8 585 854 70; E-mail: Agneta.K.Nordberg@ki.se.
Abstract: Studies in carriers of mutations that cause early-onset familial Alzheimer's disease (eoFAD) are of significant interest. We showed previously that regional glucose hypometabolism could be detected many years before disease onset in presenilin 1 (PSEN1) mutation carriers. Here we studied four members of a family with a Met146Val PSEN1 mutation, two symptomatic carriers and two non-carriers, longitudinally with 18F-FDG PET over a period of about two and four years, respectively. The two mutation carriers showed global cortical glucose hypometabolism over time with the most distinct decline occurring in the posterior cingulate, the parietal and parietotemporal cortex, which was also observed when compared with a group of 23 healthy controls and a group 27 sporadic Alzheimer's disease (sAD) patients. This decline correlated with cognitive deterioration over time as measured by neuropsychological tests. Postmortem examination of brain tissue revealed substantially elevated levels of AD type neuropathology in terms of neuritic plaques and neurofibrillary tangles in the two mutation carriers compared with a reference group of sAD patients. In the mutation carriers, the amount of neuritic plaques but not neurofibrillary tangles correlated hereby significantly with regional glucose metabolism as measured by 18F-FDG on the last scanning occasions, which were performed four and approximately five years before death, respectively. We here show that FDG PET can depict in vivo the aggressive disease progression in eoFAD mutation carriers in relationship to neuropathology.
Keywords: Early-onset familial Alzheimer's disease, FDG, longitudinal studies, neuritic plaques, neurofibrillary tangles, postitron emission tomography, postmortem pathology, presenilin 1
DOI: 10.3233/JAD-2011-101563
Journal: Journal of Alzheimer's Disease, vol. 24, no. 3, pp. 495-506, 2011
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl